Mild To Moderate Erectile Dysfunction Study
Public ClinicalTrials.gov record NCT00137072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Parallel Study of Men With Mild to Moderate Erectile Dysfunction to Evaluate the Efficacy of Viagra 8 Hours Post-Dose
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety/Efficacy of 100-mg Viagra at 8 hours post dose in men with mild to moderate erectile dysfunction
Study identification
- NCT ID
- NCT00137072
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 355 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Feb 2006 (Actual)
- Last update posted
- Feb 1, 2021
2005 – 2006
United States locations
- U.S. sites
- 33
- U.S. states
- 16
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | — | — |
| Pfizer Investigational Site | Homewood | Alabama | — | — |
| Pfizer Investigational Site | Hoover | Alabama | — | — |
| Pfizer Investigational Site | Huntsville | Alabama | — | — |
| Pfizer Investigational Site | Phoenix | Arizona | — | — |
| Pfizer Investigational Site | Beverly Hills | California | — | — |
| Pfizer Investigational Site | La Mesa | California | — | — |
| Pfizer Investigational Site | Newport Beach | California | — | — |
| Pfizer Investigational Site | San Diego | California | — | — |
| Pfizer Investigational Site | Aurora | Colorado | — | — |
| Pfizer Investigational Site | Middlebury | Connecticut | — | — |
| Pfizer Investigational Site | Waterbury | Connecticut | — | — |
| Pfizer Investigational Site | Gainesville | Florida | — | — |
| Pfizer Investigational Site | New Port Richey | Florida | — | — |
| Pfizer Investigational Site | South Miami | Florida | — | — |
| Pfizer Investigational Site | Tallahassee | Florida | — | — |
| Pfizer Investigational Site | Tampa | Florida | — | — |
| Pfizer Investigational Site | Fort Wayne | Indiana | — | — |
| Pfizer Investigational Site | Jeffersonville | Indiana | — | — |
| Pfizer Investigational Site | Des Moines | Iowa | — | — |
| Pfizer Investigational Site | New Orleans | Louisiana | — | — |
| Pfizer Investigational Site | Shreveport | Louisiana | — | — |
| Pfizer Investigational Site | Hattiesburg | Mississippi | — | — |
| Pfizer Investigational Site | Las Vegas | Nevada | — | — |
| Pfizer Investigational Site | Bay Shore | New York | — | — |
| Pfizer Investigational Site | Kingston | New York | — | — |
| Pfizer Investigational Site | New York | New York | — | — |
| Pfizer Investigational Site | Poughkeepsie | New York | — | — |
| Pfizer Investigational Site | Cincinnati | Ohio | — | — |
| Pfizer Investigational Site | Nashville | Tennessee | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Lacey | Washington | — | — |
| Pfizer Investigational Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00137072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 1, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00137072 live on ClinicalTrials.gov.